Editorial
Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1734-1738
.
(30 September 2022)
Complex glandular pattern as an independent predictor of survival probability in lung adenocarcinoma
Translational Lung Cancer Research
2022;
11
(9)
:1739-1741
.
(30 September 2022)
Consensus
International expert consensus on immunotherapy for early-stage non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1742-1762
.
(30 September 2022)
International consensus on radiotherapy in metastatic non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1763-1795
.
(30 September 2022)
Original Article
Tumoral PD-L1 does not impact time to treatment discontinuation in EGFR mutated non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor—a Danish cohort study
Translational Lung Cancer Research
2022;
11
(9)
:1796-1808
.
(30 September 2022)
Development and validation of a polygenic hazard score to predict prognosis and adjuvant chemotherapy benefit in early-stage non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1809-1822
.
(30 September 2022)
Changes in serum transforming growth factor-beta concentration as a predictive factor for radiation-induced lung injury onset in radiotherapy-treated patients with locally advanced lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1823-1834
.
(30 September 2022)
Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies
Translational Lung Cancer Research
2022;
11
(9)
:1835-1846
.
(30 September 2022)
Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study
Translational Lung Cancer Research
2022;
11
(9)
:1847-1857
.
(30 September 2022)
Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients
Translational Lung Cancer Research
2022;
11
(9)
:1858-1865
.
(30 September 2022)
Impact of gender on response to immune checkpoint inhibitors in patients with non-small cell lung cancer undergoing second- or later-line treatment
Translational Lung Cancer Research
2022;
11
(9)
:1866-1876
.
(30 September 2022)
USO1 expression is dysregulated in non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1877-1895
.
(30 September 2022)
Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality
Translational Lung Cancer Research
2022;
11
(9)
:1896-1911
.
(30 September 2022)
PTS is activated by ATF4 and promotes lung adenocarcinoma development via the Wnt pathway
Translational Lung Cancer Research
2022;
11
(9)
:1912-1925
.
(30 September 2022)
Value of 18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the differential diagnosis of sarcoidosis and lung cancer with lymph node metastasis: a retrospective study
Translational Lung Cancer Research
2022;
11
(9)
:1926-1935
.
(30 September 2022)
Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
Translational Lung Cancer Research
2022;
11
(9)
:1936-1950
.
(30 September 2022)
Adjuvant treatment for patients with incidentally resected limited disease small cell lung cancer—a retrospective study
Translational Lung Cancer Research
2022;
11
(9)
:1951-1960
.
(30 September 2022)
iMDT Corner
Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report
Translational Lung Cancer Research
2022;
11
(9)
:1961-1966
.
(30 September 2022)
Case Report
MYC amplification-conferred primary resistance to capmatinib in a MET-amplified NSCLC patient: a case report
Translational Lung Cancer Research
2022;
11
(9)
:1967-1972
.
(30 September 2022)
Cytokine release syndrome in a patient with non-small cell lung cancer on ipilimumab and nivolumab maintenance therapy after vaccination with the mRNA-1273 vaccine: a case report
Translational Lung Cancer Research
2022;
11
(9)
:1973-1976
.
(30 September 2022)
